Literature DB >> 35837557

Neutrophils inhibit CD8+ T cells immune response by arginase-1 signaling in patients with sepsis.

Xiao-Kang Dai1, Zhen-Xing Ding1, Yuan-Yuan Tan1, Hua-Rui Bao1, Dong-Yao Wang2,3,4, Hong Zhang1.   

Abstract

BACKGROUND: Patients with sepsis often exhibit an acute inflammatory response, followed by an immunosuppressive phase with a poor immune response. However, the underlying mechanisms have not been fully elucidated.
METHODS: We sought to comprehensively characterize the transcriptional changes in neutrophils of patients with sepsis by transcriptome sequencing. Additionally, we conducted a series of experiments, including real-time quantitative polymerase chain reaction (RT-qPCR) and flow cytometry to investigate the role of arginase-1 signaling in sepsis.
RESULTS: Through the analysis of gene expression profiles, we identified that the negative regulation of T cell activation signaling was enriched, and the expression of arginase-1 was high in neutrophils from patients with sepsis. Furthermore, we conducted flow cytometry and found that the function of CD8+ T cells in septic patients was impaired. Moreover, neutrophils from septic patients inhibited the percentage of polyfunctional effector CD8+ T cells through arginase-1. Additionally, the proportions of granzyme B+IFN-γ+CD8+ T and TNF-α+IFN-γ+CD8+ T cells increased after inhibition of arginase-1 signaling.
CONCLUSION: The impaired effector function of CD8+ T cells could be restored by blocking arginase-1 signaling in patients with sepsis. Copyright: © World Journal of Emergency Medicine.

Entities:  

Keywords:  Arginase-1; Effector CD8+ T cells; Interferon-γ; Neutrophils; Sepsis

Year:  2022        PMID: 35837557      PMCID: PMC9233973          DOI: 10.5847/wjem.j.1920-8642.2022.068

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  36 in total

1.  Arginase I release from activated neutrophils induces peripheral immunosuppression in a murine model of stroke.

Authors:  Trisha R Sippel; Takeru Shimizu; Frank Strnad; Richard J Traystman; Paco S Herson; Allen Waziri
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

Review 2.  Neutrophil pyroptosis: new perspectives on sepsis.

Authors:  Lu Liu; Bingwei Sun
Journal:  Cell Mol Life Sci       Date:  2019-03-14       Impact factor: 9.261

Review 3.  Transforming Growth Factor-β Signaling in Immunity and Cancer.

Authors:  Eduard Batlle; Joan Massagué
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

4.  Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression.

Authors:  Jingjing Cong; Xianwei Wang; Xiaohu Zheng; Dong Wang; Binqing Fu; Rui Sun; Zhigang Tian; Haiming Wei
Journal:  Cell Metab       Date:  2018-07-19       Impact factor: 27.287

Review 5.  Neutrophils in cancer: prognostic role and therapeutic strategies.

Authors:  Alberto Ocana; Cristina Nieto-Jiménez; Atanasio Pandiella; Arnoud J Templeton
Journal:  Mol Cancer       Date:  2017-08-15       Impact factor: 27.401

6.  Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24+CD38hi B Cells.

Authors:  Binqing Fu; Dongyao Wang; Xiaokun Shen; Chuang Guo; Yanyan Liu; Ying Ye; Rui Sun; Jiabin Li; Zhigang Tian; Haiming Wei
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

7.  Distinguishing Sepsis From Infection by Neutrophil Dysfunction: A Promising Role of CXCR2 Surface Level.

Authors:  Chutima Seree-Aphinan; Polathep Vichitkunakorn; Raphatphorn Navakanitworakul; Bodin Khwannimit
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

8.  SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.

Authors:  Florian Reizine; Mathieu Lesouhaitier; Murielle Gregoire; Kieran Pinceaux; Arnaud Gacouin; Adel Maamar; Benoit Painvin; Christophe Camus; Yves Le Tulzo; Pierre Tattevin; Matthieu Revest; Audrey Le Bot; Alice Ballerie; Berengère Cador-Rousseau; Mathieu Lederlin; Thomas Lebouvier; Yoann Launey; Maelle Latour; Clotilde Verdy; Delphine Rossille; Simon Le Gallou; Joelle Dulong; Caroline Moreau; Claude Bendavid; Mikael Roussel; Michel Cogne; Karin Tarte; Jean-Marc Tadié
Journal:  J Clin Immunol       Date:  2021-01-02       Impact factor: 8.317

9.  NKp30+ NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B.

Authors:  Xiaokun Shen; Binqing Fu; Yanyan Liu; Chuang Guo; Ying Ye; Rui Sun; Jiabin Li; Zhigang Tian; Haiming Wei
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

Review 10.  Update on Neutrophil Function in Severe Inflammation.

Authors:  Esmaeil Mortaz; Shamila D Alipoor; Ian M Adcock; Sharon Mumby; Leo Koenderman
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.